April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Baseline CSLO Optic Nerve Data and VF Progression in Treated Glaucoma
Author Affiliations & Notes
  • Christopher C. Teng
    Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
  • Gustavo V. De Moraes
    Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
    Ophthalmology, New York University School of Medicine, New York, New York
  • Sung Chul Park
    Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
  • Celso Tello
    Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
  • Robert Ritch
    Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
  • Jeffrey M. Liebmann
    Ophthalmology, Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
    Ophthalmology, New York University School of Medicine, New York, New York
  • Footnotes
    Commercial Relationships  Christopher C. Teng, None; Gustavo V. De Moraes, None; Sung Chul Park, None; Celso Tello, Diopsys Inc. (F); Robert Ritch, Diopsys Inc. (F, C), Pfizer Inc. (C), Topcon Medical Systems Inc (F, C); Jeffrey M. Liebmann, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (C), Diopsys Inc. (F, C), Pfizer Inc. (C), Topcon Medical Systems Inc (F, C)
  • Footnotes
    Support  Supported by a Clinician Scientist Grant from the American Glaucoma Society and the Joseph and Geraldine LaMotta Research Fund of the New York Glaucoma Research Institute, New York, NY.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4142. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher C. Teng, Gustavo V. De Moraes, Sung Chul Park, Celso Tello, Robert Ritch, Jeffrey M. Liebmann; Baseline CSLO Optic Nerve Data and VF Progression in Treated Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4142.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate whether baseline Confocal Scanning Laser Ophthalmoscopy (CSLO) parameters are associated with VF progression in eyes with established and treated glaucoma.

Methods: : Retrospective observational cohort. Treated glaucoma patients (abnormal achromatic perimetry and optic disc appearance), with reliable baseline CSLO imaging using Heidelberg Retinal Tomograph (HRT II), and >=5 24-2 SITA VF tests after the HRT were included. VF progression was evaluated using automated pointwise linear regression (PLR). VF progression was defined as at least 2 adjacent test points in the same hemifield progressing >1.0 dB/yr at p<0.01. Stereometric parameters and Moorfields Regression Analysis (MRA) results were analyzed in univariate and multivariate models adjusted for follow-up time to determine the role of baseline variables in the prediction of VF progression outcomes. Variables with p<=0.10 in the univariate analysis were entered in the multivariate analysis.

Results: : 115 eyes (115 patients; mean age, 66.5±12.7; mean baseline MD, -4.2±3.6; 58% women, 88% European descent) were analyzed. 35 patients had VF progression. Patients performed 9.2±2.5 VF tests spanning 4.9±1.4 yrs after the baseline CSLO. In the univariate model, significant variables (p<0.05) were: disc area, cup area, rim area, rim volume, cup shape measure, mean RNFL, rim area/disc area ratio, FSM discriminant function value, RB discriminant function value, and Moorfields Regression Analysis. In the multivariate model, when evaluating CSLO measures, variables associated with progression were global cup shape measure (OR=1.08, p<0.01); inferotemporal cup area (OR=1.10, p<0.01); and FSM discriminant function value (OR=0.997, p<0.01). When evaluating all MRA variables, only inferotemporal MRA was significant (OR=4.37, p<0.01).

Conclusions: : In assessing baseline CSLO parameters in patients with treated glaucoma, an abnormal inferotemporal disc was associated with VF progression. This may indicate that the inferotemporal disc is more susceptible to glaucomatous damage, leading to VF progression.

Keywords: imaging/image analysis: clinical • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • optic nerve 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×